CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 249 enrolled
Drug / intervention
Trimethoprim-Sulfamethoxazoledrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02024867
NCT02024867N/ACompleted
CompareCT.gov

Randomized Non-inferiority Trial of 3 Versus 10 Days of Trimethoprim-Sulfamethoxazole in Community-Associated Skin Abscesses After Surgical Drainage

Lucy Holmes, MD·interventional·Posted Dec 31, 2013·Updated Oct 19, 2015

In Brief

A clinical study evaluating Trimethoprim-Sulfamethoxazole for Skin Disease, Bacterial and Abscess. Completed, enrolled 249 participants across 1 site.

Detailed Summary

The objective of this study is to determine if there is a difference in treatment failures and recurrent skin infections when patients are given 3 or 10 days of antibiotics for uncomplicated skin abscesses after they have been surgically drained.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Disease, Bacterial, Abscess
CountriesUnited States
CollaboratorsNew York State Department of Health, Women & Children's Hospital of Buffalo

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 31, 2013
Enrollment StartFeb 1, 2010
Primary CompletionJan 1, 2012
Study CompletionJul 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 12.5 years ago

Interventions

Trimethoprim-Sulfamethoxazoledrug

3 versus 10 days of drug